Skip to main content

Find Clinical Trials

Home
Conditions
Cutaneous Toxicity From ICI Therapy

Clinical trial condition

Cutaneous Toxicity From ICI Therapy

Explore clinical trials studying Cutaneous Toxicity From ICI Therapy. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Cutaneous Toxicity From ICI Therapy trial results

Completed

Analysis of Reporting of Cutaneous Toxicities Associated With Immune Checkpoint Inhibitors

NCT04898751

Conditions: Cutaneous Toxicity From ICI Therapy
Locations: Sidney Kimmel Comprehensive Care Center Baltimore, Maryland, United States

View Trial Details